MAP
GMED icon

Moody Aldrich Partners’s Globus Medical GMED Stock Holding History

Moody Aldrich Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-74,027
Closed -$3.53M – 166
2020
Q2 		$3.53M Buy
74,027
+10,917
+17% +$527K 0.75% 58
2020
Q1 		$2.68M Sell
63,110
-36
-0.1% -$1.78K 0.81% 54
2019
Q4 		$3.72M Buy
63,146
+557
+0.9% +$30.2K 0.76% 57
2019
Q3 		$3.2M Sell
62,589
-604
-1% -$28.8K 0.85% 50
2019
Q2 		$2.67M Sell
63,193
-41,130
-39% -$1.79M 0.68% 60
2019
Q1 		$5.16M Buy
104,323
+14,124
+16% +$639K 1.45% 22
2018
Q4 		$3.9M Sell
90,199
-5,182
-5% -$259K 1.28% 31
2018
Q3 		$5.41M Buy
95,381
+15,261
+19% +$803K 1.56% 20
2018
Q2 		$4.04M Buy
80,120
+41,112
+105% +$2.14M 1.44% 25
2018
Q1 		$1.94M Buy
+39,008
New +$1.83M 1.25% 33
2016
Q4 		– Sell
-63,360
Closed -$1.43M – 95
2016
Q3 		$1.43M Buy
63,360
+5,890
+10% +$138K 1% 47
2016
Q2 		$1.37M Buy
57,470
+32,840
+133% +$788K 1.13% 35
2016
Q1 		$585K Buy
+24,630
New +$602K 1.23% 31

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Moody Aldrich Partners's GMED Position: Q3 2020 in Review

Moody Aldrich Partners sold out of Globus Medical (GMED) in Q3 2020, closing a stake of 74,027 shares — an estimated $3.53M sold.

Moody Aldrich Partners first reported a position in GMED in Q1 2016 and held it in 13 quarters. The position peaked at $5.41M in Q3 2018. 344 funds tracked by Wall St. Rank hold GMED as of Q3 2020.

  • Moody Aldrich Partners reported no remaining Globus Medical position as of Q3 2020 after selling out during the quarter.
  • Moody Aldrich Partners sold 74,027 Globus Medical shares in Q3 2020, an estimated $3.53M.
  • Moody Aldrich Partners first reported a position in Globus Medical in Q1 2016 and held it in 13 quarters.
  • Moody Aldrich Partners's Globus Medical position peaked at $5.41M in Q3 2018.
  • 344 funds tracked by Wall St. Rank held Globus Medical as of Q3 2020.

Based on Moody Aldrich Partners's 13F filing for Q3 2020, filed 12 Nov 2020.